Pharmacodynamic study of F(ab′)2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

Journal of Clinical Investigation

Volumn 86, Issue 2, 1990, Pages 651-659

  Gold, H K ^a   Gimple, L W ^b   Yasuda, T ^b   Leinbach, R C ^b   Werner, W ^b   Holt, R ^b   Jordan, R ^b   Berger, H ^b   Collen, D ^b   Coller, B S ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Anti platelet glycoprotein IIb IIIa antibody; Bleeding time; Coronary artery thrombosis; Ischemic heart disease; Platelet aggregation inhibition

Indexed keywords

GLYCOPROTEIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA PECTORIS; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; DRUG EVALUATION; HUMAN; IMMUNOGLOBULINS, FAB; IMMUNOTHERAPY; MIDDLE AGE; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025033952     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI114757     Document Type: Article

References (27)

1. Health, United States 1981. U.S. Department of Health and Human Services, National Center for Health Statistics, Hyattsville, MD. DHHS Publication No. (PHS) 82-1232.
2. Antiplatelet Trialists' Collaboration. 1988. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br. Med. J. 296:320-331.
3. Coller, B. S. 1989. Activation-specific platelet antigens. In Platelet Immunobiology: Molecular and Clinical Aspects. T. J. Kunicki and J. George, editors. J.P. Lippincott Co., Philadelphia. 166-169.
4. Plow, E. F., and M. H. Ginsberg. 1988. Cellular adhesion: GPIIb/IIIa as a prototypic adhesion receptor. Prog. Hemostasis Thromb. 9:117-156.
5. Coller, B. S. 1985. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J. Clin. Invest. 76:101-108.
6. 2 fragments of a monoclonal antibody. Blood. 66:1456-1450.
7. Coller, B. S., J. D. Folts, J. D. Scudder, and S. R. Smith. 1986. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model. Blood. 68:783-786.
8. Gold, H. K., B. S. Coller, T. Yasuda, T. Saito, J. T. Fallon, J. L. Guerrero, R. C. Leinbach, A. A. Ziskind, and D. Collen. 1988. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal anti-platelet GPIIb/IIIa antibody in a dog model. Circulation. 77:670-677.
9. Fitzgerald, D. F., F. Wright, and G. A. Fitzgerald. 1989. Increased thromboxane biosynthesis during coronary thrombolysis: evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. Circ. Res. 65:83-94.
10. Yasuda, T., H. K. Gold, J. T. Fallon, R. C. Leinbach, J. L. Guerrero, L. E. Scudder, M. Kanke, D. Shealy, M. J. Ross, D. Collen, et al. 1988. A monoclonal antibody against the platelet GPIIb/IIIa receptor prevents coronary artery reocclusion following reperfusion with recombinant tissue-type plasminogen activator in dogs. J. Clin. Invest. 81:1284-1291.
11. 2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart. J. Mol. Cell. Cardiol. 21:393-405.
12. Bates, E. R., M. J. McGillem, J. K. Mickelson, B. Pitt, and G. B. J. Mancini. 1988. A monoclonal antibody to the platelet receptor GPIIb/IIIa (7E3) prevents acute thrombosis in a canine model of coronary angioplasty. Circulation. 78:11?-189. (Abstr.)
13. 2 in monkeys. Blood. 70(Suppl. I):349a. (Abstr.)
14. 2 in monkeys. Blood. 70:337a. (Abstr.)
15. Coller, B. S., L. E. Scudder, H. J. Berger, and J. D. Iuliucci. 1988. Inhibition of human platelet function in vivo with a monoclonal antibody: with observations on the newly dead as experimental subjects. Ann. Intern. Med. 109:635-638.
16. Gold, H. K., J. A. Johns, R. C. Leinbach, T. Yasuda, E. Grossbard, R. Zusman, and D. Collen. 1987. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation. 75:1192-1199.
17. Shulman, N. R., and J. V. Jordan. 1987. Platelet kinetics. In Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 2nd Edition. R. W. Colman, J. Hirsh, V. J. Marder, and E. W. Salzman, editors. J.B. Lippincott Co., Philadelphia. 431-451.
18. Clauss, A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemalol. 17:237-245.
19. Wencel-Drake, J. D. 1990. Plasma membrane GPIIb/IIIa: evidence for a cycling receptor pool. Am. J. Pathol. 136:61-70.
20. Friedman, M. 1971. The coronary thrombus: its origin and fate. Hum. Pathol. 2:81-128.
21. Davies, M. J., and A. C. Thomas. 1985. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br. Heart J. 53:363-373.
22. Swahn, E., and L. Wallentin. 1987. Platelet reactivity in unstable coronary artery disease. Thromb. Haemostasis. 57:302-305.
23. Coller, B. S., J. D. Folts, S. R. Smith, L. E. Scudder, and R. Jordan. 1989. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Circulation. 80:1766-1774.
24. Hanson, S. R., F. I. Pareti, Z. M. Fuggeri, U. M. Marzac, J. J. Kunicki, P. R. Montgomery, T. S. Zimmerman, and L. Harker. 1988. Effects of monoclonal antibodies against the platelet glycoprotein IIb/ IIIa complex on thrombosis and hemostasis in the baboon. J. Clin. Invest. 81:149-158.
25. Torem, S., P. A. Schneider, and S. R. Hanson. 1988. Monoclonal antibody-induced inhibition of platelet function: effects on hemostasis and vascular graft thrombosis in baboons. J. Vasc. Surg. 7:172-180.
26. Coller, B. S., U. Seligsohn, A. Zivelin, E. Zwang, A. Lusky, and M. Modan. 1986. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann's thrombasthenia in Iraqi-Jewish and Arab populations of Israel: comparison of techniques for carrier detection. Br. J. Haematol. 62:723-735.
27. Takami, H., W. L. Nichols, S. E. Kaese, and J. W. Bowie. 1987. Infusion study of monoclonal antibodies against porcine platelet membrane GPIIb and GPIIb/IIIa: differential effect on platelet function and bleeding time. Blood. 70(Suppl. 1):344a. (Abstr.)